Duchenne Muscular Dystrophy Market Size to Exceed USD 2.1 billion by 2031 | CAGR of 4.7%

Allied Market Research has published a study report with the title Duchenne Muscular Dystrophy Market Size was Valued at USD 1.3 billion in 2021 and is Projected to Garner USD 2.1 billion by 2031, registering a CAGR of 4.7% from 2022 to 2031.

Duchenne Muscular Dystrophy (DMD) is a genetic disorder that primarily affects males and is caused by mutations in the dystrophin gene. This gene encodes for a protein called dystrophin, which is crucial for maintaining the structural integrity of muscle fibers.

Individuals with DMD typically show signs of muscle weakness and wasting in early childhood, often beginning in the legs and pelvis and progressing to the upper body and arms. They may have difficulty walking, climbing stairs, or standing up from a seated position. As the disease progresses, individuals with DMD may develop scoliosis (curvature of the spine), respiratory and cardiac complications, and other health problems.

Get Sample PDF Report with Graphs and Figures Here: https://www.alliedmarketresearch.com/request-sample/16015

Top Duchenne Muscular Dystrophy Companies: -

• F Hoffmann-La Roche AG
• FibroGen, Inc
• GlaxoSmithKline plc
• Italfarmaco S.p.A.
• Nippon Shinyaku Co., Ltd
• Pfizer Inc.
• PTC Therapeutics
• Santhera Pharmaceuticals Inc
• Sarepta therapeutics
• Wave life sciences ltd.

Duchenne Muscular Dystrophy Market segmentation can be done based on several factors, including:

Based on therapeutic area, the molecular based therapies segment held the highest market share in 2021, accounting for around three-fifths of the global Duchenne muscular dystrophy market, and is estimated to maintain its leadership status throughout the forecast period. In addition, the same segment is projected to manifest the highest CAGR of 5.0% from 2022 to 2031, owing to R & D activities for exon skipping drugs, strong product pipeline and significant product launch by key players. The report also discusses steroid therapy segment.

Based on distribution channel, the hospital pharmacies segment accounted for the largest share in 2021, contributing to more than three-fifths of the global Duchenne muscular dystrophy market, and is projected to maintain its lead position during the forecast period. This is owing to significant rise in the number of diagnosis through hospitals. However, the drug store & retail pharmacies segment is expected to portray the largest CAGR of 5.4% from 2022 to 2031, owing to the rise in the approval of drugs and their availability in drug store & retail pharmacies.

Based on region, North America held the highest market share in terms of revenue in 2021, accounting for more than half of the global Duchenne muscular dystrophy market, and is likely to dominate the market during the forecast period. This is owing to technological advancements in Duchenne muscular dystrophy treatment and presence of key players & robust hospital infrastructure in the region. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.9% from 2022 to 2031. This is owing to rise in cases of Duchenne muscular dystrophy, approval of drugs, development of healthcare infrastructure, and increase in investments projects in the region.

What are the Recent Trends in the Duchenne Muscular Dystrophy Market?

Rise in the incidence of the Duchenne muscular dystrophy (DMD) and surge in need for better healthcare services drive the growth of the global Duchenne muscular dystrophy market. However, inflated cost of treatments for Duchenne muscular dystrophy restricts the market growth. On the other hand, increase in government spending on the pharmaceutical and biotechnology sectors in developing countries, the development of healthcare infrastructure, and rise in demand for innovative treatments for Duchenne muscular dystrophy present new opportunities in the coming years.

Purchase the Report:
https://www.alliedmarketresearch.com/purchase-enquiry/16015

Our Market Research Solution Provides You Answer to Below Mentioned Question:

• Which are the driving factors responsible for the growth of market?
• Which are the roadblock factors of this market?
• What are the new opportunities, by which market will grow in coming years?
• What are the trends of this market?
• Which are main factors responsible for new product launch?
• How big is the global & regional market in terms of revenue, sales and production?
• How far will the market grow in forecast period in terms of revenue, sales and production?
• Which region is dominating the global market and what are the market shares of each region in the overall market in 2022?
• How will each segment grow over the forecast period and how much revenue will these segments account for in 2030?
• Which region has more opportunities?

By Region Outlook

• North America
(U.S., Canada, Mexico)
• Europe
(Germany, France, UK, Italy, Spain, Rest of Europe)
• Asia-Pacific
(Japan, China, India, Rest of Asia-Pacific)
• LAMEA
(Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Get Full Report:

https://www.alliedmarketresearch.com/duchenne-muscular-dystrophy-therapeutics-market

Top Trending Report:

AT-Home Testing Market: https://www.alliedmarketresearch.com/at-home-testing-market-A31866

Resuscitation Devices Market: https://www.alliedmarketresearch.com/resuscitation-devices-market-A11454

Gene Therapy Market: https://www.alliedmarketresearch.com/gene-therapy-market

3D Cell Culture Market: https://www.alliedmarketresearch.com/3d-cell-cultures-market

Molecular diagnostics market: https://www.alliedmarketresearch.com/molecular-diagnostics-market

Digital Pathology Market: https://www.alliedmarketresearch.com/digital-pathology-market

MRI Coils Market: https://www.alliedmarketresearch.com/mri-coils-market-A14839

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

This release was published on openPR.